Sofgen Pharma S.A. (PROCF)
OTCMKTS
· Delayed Price · Currency is USD
0.0251
0.00 (0.00%)
Apr 27, 2026, 9:30 AM EST
Sofgen Pharma Revenue
In the year 2024, Sofgen Pharma had annual revenue of $373.80M, down -11.79%. Sofgen Pharma had revenue of $118.41M in the quarter ending September 30, 2023, with 7.25% growth.
Revenue
373.80M
Revenue Growth
-8.48%
P/S Ratio
0.16
Revenue / Employee
83.10K
Employees
4,498
Market Cap
58.41M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Earth Science Tech | 34.87M |
| Radnostix | 13.07M |
| Growth Stalk Holdings | 583.34K |
| Jushi Holdings | 262.91M |
| MariMed | 159.83M |
| Kaya Holdings | 26.69K |
| Healthy Extracts | 4.51M |
| Bio Essence | 1.90M |
Sofgen Pharma News
- 1 year ago - Procaps Group Secures $130 Million in Equity Investment and Completes Comprehensive Debt Restructuring, as New Investors Take Over Strategic Leadership - GlobeNewsWire
- 1 year ago - Nasdaq delists Colombia's Procaps Group due to financial shortfalls - Invezz
- 2 years ago - Sofgen Pharma Transcript: Investor Update - Transcripts
- 2 years ago - Sofgen Pharma Earnings Call Transcript: Q2 2023 - Transcripts
- 3 years ago - Sofgen Pharma Earnings Call Transcript: Q1 2023 - Transcripts